Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...

Funding is provided by the Advanced Research Projects Agency for Health (ARPA-H), an ... with the majority of new drugs ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research Report ... The company has shown consistent execution in its clinical programs, ...

Additional member institutions will be announced and onboarded in subsequent phases. “The velocity of AI innovations ... we translate discovery into application and interconnect clinical care, ...

They used advanced health monitoring technology to gain insights into the rats’ sleep patterns, including the amount of sleep ...